Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Huben

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1994
Staging and grading in the survival of adrenal carcinomasG C Zografos, D Driscoll, C Karakousis, et al.
Urology|February 1, 1990
Malignant phyllodes tumor of prostateA Löpez-Beltran, J F Gaeta, R Huben, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 1, 1994
A comparison of prostate cancer patients in Japan and the USAK Imai, Y Takahashi, S Nakata, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Pharmacokinetics of Anandron in patients with advanced carcinoma of the prostateL Pendyala, P J Creaven, R Huben, et al.
Progress in Clinical and Biological Research|January 1, 1987
Clinical pharmacokinetics of a new antiandrogen Anandron (RU 23908)L Pendyala, P J Creaven, R Huben, et al.
The Journal of Urology|April 1, 1985
Secondary tumors of the prostateT A Zein, R Huben, W Lane, et al.
Urology|December 1, 1982
Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National SurveyR Huben, N Natarajan, E Pontes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I trial of a new nitrosourea, CGP 6809, given every 2 weeksP J Creaven, J W Cowens, R Huben, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 1997
If you 'watch and wait,' prostate cancer may progress dramaticallyR R Allison, A Schulsinger, V Vongtama, et al.
Cancer Genetics and Cytogenetics|June 1, 1988
New cytogenetic subtype of renal tumorsP Dal Cin, A A Sandberg, R Huben, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1994
Staging and grading in the survival of adrenal carcinomasG C Zografos, D Driscoll, C Karakousis, et al.
Urology|February 1, 1990
Malignant phyllodes tumor of prostateA Löpez-Beltran, J F Gaeta, R Huben, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 1, 1994
A comparison of prostate cancer patients in Japan and the USAK Imai, Y Takahashi, S Nakata, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Pharmacokinetics of Anandron in patients with advanced carcinoma of the prostateL Pendyala, P J Creaven, R Huben, et al.
Progress in Clinical and Biological Research|January 1, 1987
Clinical pharmacokinetics of a new antiandrogen Anandron (RU 23908)L Pendyala, P J Creaven, R Huben, et al.
The Journal of Urology|April 1, 1985
Secondary tumors of the prostateT A Zein, R Huben, W Lane, et al.
Urology|December 1, 1982
Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National SurveyR Huben, N Natarajan, E Pontes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I trial of a new nitrosourea, CGP 6809, given every 2 weeksP J Creaven, J W Cowens, R Huben, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 1997
If you 'watch and wait,' prostate cancer may progress dramaticallyR R Allison, A Schulsinger, V Vongtama, et al.
Cancer Genetics and Cytogenetics|June 1, 1988
New cytogenetic subtype of renal tumorsP Dal Cin, A A Sandberg, R Huben, et al.
Pageof 3